Latest Breaking News On - Prnewswire immunogenesis - Page 1 : comparemela.com

ImmunoGenesis Doses First Patient in Phase 1a/1b Clinical Trial of IMGS-001 in Relapsed or Refractory Advanced Solid Tumors

/PRNewswire/ ImmunoGenesis, a clinical-stage biotechnology company developing science-driven immunotherapies, today announced the first patient has been.

United statesJennifer guinanPrnewswire immunogenesisJames barlowJeremy bartonUniversity of texas md anderson cancer centerCancer focus fundResearch institute of texasCancer centerImmunogenesis presidentImmunogenesis acting chief medical officerCancer preventionResearch instituteStrategic marketing

ImmunoGenesis Appoints Oncology Research Veteran to Lead Immuno-Oncology Clinical Development Targeting Immune-Excluded, Cold Cancers

/PRNewswire/ ImmunoGenesis, a clinical-stage biotechnology company developing science-driven immune therapies, announced the appointment of seasoned.

University of pennsylvaniaUnited statesPhiladelphia college of pharmacyCharles schweizerJames barlowJennifer guinanPrnewswire immunogenesisProduct developmentUniversity of the sciencesImmunogenesis incClinical developmentSenior vice presidentTherapeutic area headImmunogenesis presidentVice presidentClinical operations

ImmunoGenesis Expands R&D, Clinical and Business Development Teams and Opens Research Laboratory

ImmunoGenesis Expands R&D, Clinical and Business Development Teams and Opens Research Laboratory
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesSand hillJames barlowAnnemarie moseleyJennifer guinanPrnewswire immunogenesisCassandra harrisonWilliam tannerChristine gagliardiMatthew hembergerChristine gaglardiScott cullisonBellicum pharmaceuticalsImmunogenesis incStride bdcom consultingData sciences at mersana therapeutics